GlassScriptPhysician profile
Zvi J Schiffman
NPI 1528036779
$31,804.24
in general payments reported to CMS, 2019-2025
70 companies · $6,363 in 2025
The $6,363 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $6,182 · 2020: $3,879 · 2021: $5,884 · 2022: $1,743 · 2023: $4,112 · 2024: $3,641 · 2025: $6,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,403 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,760 · Consulting Fee: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,402.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,759.91 |
| Consulting Fee | $953.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $8,185.27 | 2019-2025 | |
| Avyxa Pharma, LLC | $3,272.96 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,469.13 | 2019-2025 | |
| Palette Life Sciences, INC. | $1,752.15 | 2020-2021 | |
| Janssen Biotech, INC. | $1,555.66 | 2019-2025 | Erleada, Akeega, Rybrevant |
| Boston Scientific Corporation | $1,460.98 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Procept Biorobotics Corporation | $1,281.04 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Janssen Scientific Affairs, LLC | $953.75 | 2023 | |
| Dendreon Pharmaceuticals LLC | $917.29 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $855.05 | 2019-2025 | Xtandi, Padcev |
| Myriad Genetic Laboratories, INC. | $767.30 | 2021-2025 | Prolaris, Myrisk |
| Merck Sharp & Dohme LLC | $682.86 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Ferring Pharmaceuticals INC. | $617.91 | 2019-2025 | Adstiladrin |
| Janssen Research & Development, LLC | $554.37 | 2020 | |
| Angiodynamics, INC. | $546.39 | 2023-2025 | Nanoknife, Biosentry Tract Sealant System |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $432.40 | 2019-2025 | Lupron Depot, Botox |
| Sumitomo Pharma America, INC. | $408.46 | 2023-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $318.04 | 2019-2025 | Itind System |
| Tolmar Pharmaceuticals, INC. | $293.38 | 2019-2022 | |
| Convatec INC. | $271.93 | 2022-2025 | |
| Urogen Pharma, INC. | $237.27 | 2022-2025 | Jelmyto |
| Accord Healthcare, INC. | $228.72 | 2022-2024 | |
| Progenics Pharmaceuticals, INC. | $225.61 | 2022-2024 | Pylarify |
| Astrazeneca Pharmaceuticals LP | $223.08 | 2020-2021 | |
| C. R. Bard, INC. & Subsidiaries | $207.85 | 2025 | Aptra |
| Amgen INC. | $202.78 | 2019-2023 | Xgeva |
| Tempus Ai, INC | $195.57 | 2024-2025 | Xt Cdx |
| Endo Pharmaceuticals INC. | $175.94 | 2019-2023 | Aveed, Xiaflex |
| Axonics, INC. | $173.35 | 2020-2024 | Axonics |
| Teleflex LLC | $155.99 | 2019-2024 | |
| Allergan, INC. | $135.49 | 2019-2021 | |
| Antares Pharma, INC. | $132.31 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Profound Medical Corp. | $130.80 | 2021 | |
| Tolmar, INC. | $127.74 | 2023-2025 | Jatenzo |
| Neotract INC. | $125.14 | 2019 | |
| 180 Medical, INC. | $123.29 | 2022-2025 | Gentlecath Glide, Gentlecath |
| Edap Technomed INC | $117.89 | 2022 | |
| Ambu INC. | $98.98 | 2021-2025 | |
| Medtronic, INC. | $97.60 | 2024-2025 | Interstim |
| Biotissue Holdings INC. | $93.23 | 2022-2024 | |
| Endo USA, INC. | $90.52 | 2024-2025 | Aveed, Xiaflex |
| Verity Pharmaceuticals INC. | $88.92 | 2025 | Trelstar, Tlando |
| Blue Earth Diagnostics | $87.65 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $85.87 | 2019-2025 | Odomzo, Yonsa |
| Immunitybio, INC. | $64.32 | 2024 | |
| Baxter Healthcare | $61.19 | 2024 | Tisseel |
| Laborie Medical Technologies Corp. | $56.75 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $53.61 | 2022 | |
| Acerus Pharmaceuticals Corporation | $50.06 | 2020-2021 | |
| Travere Therapeutics, INC. | $48.68 | 2021 | |
| Healthtronics Stone Solutions, LLC | $48.54 | 2024 | Dornier Medtech |
| Telix Pharmaceuticals | $35.38 | 2022-2023 | Illuccix |
| Kowa Pharmaceuticals America, INC. | $28.08 | 2022 | |
| Urovant Sciences INC | $22.26 | 2022 | |
| Myovant Sciences INC. | $20.36 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.14 | 2019 | |
| Azurity Pharmaceuticals, INC. | $19.30 | 2025 | Azmiro |
| Steris Corporation | $19.13 | 2024 | |
| Aytu Biopharma, INC. | $18.52 | 2019 | |
| Ethicon US, LLC | $18.21 | 2019 | |
| Baudax Bio INC. | $17.05 | 2020 | |
| Alnylam Pharmaceuticals INC. | $16.46 | 2021 | |
| Innovation Technologies INC | $14.59 | 2025 | Irrisept |
| Zyla Life Sciences, INC. | $13.70 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$660.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zvi Schiffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.